mirtazapine has been researched along with lithium in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW | 1 |
| Fava, M | 1 |
| Sitsen, JM; Timmer, CJ; Voortman, G | 1 |
| Boetsch, T; Gallinat, J; Hampel, H; Hegerl, U; Herrmann, WM; Padberg, F | 1 |
| Aguglia, E; Amore, M; Delgado, PL; Gastpar, M; Hawley, C; Hirschfeld, RM; Kasper, S; Linden, M; Massana, J; Mendlewicz, J; Möller, HJ; Montgomery, SA; Nemeroff, CB; Saiz, J; Such, P; Torta, R; Versiani, M | 1 |
| Valenstein, M | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| An, Y; Chen, C; Inoue, T; Kitaichi, Y; Kusumi, I; Nakagawa, S; Song, N; Wang, C | 1 |
| An, Y; Chen, C; Inoue, T; Kitaichi, Y; Kusumi, I; Nakagawa, S; Wang, C | 1 |
| Kuramochi, S; Mimura, M; Takeuchi, H; Uchida, H; Uchida, T; Yatomi, T | 1 |
2 review(s) available for mirtazapine and lithium
| Article | Year |
|---|---|
New approaches to the treatment of refractory depression.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Pindolol; Piperazines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thyroxine; Triazoles; Triiodothyronine | 2000 |
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
Topics: Antidepressive Agents; Congresses as Topic; Cyclopropanes; Decision Trees; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Lithium; Mianserin; Milnacipran; Mirtazapine; Morpholines; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2002 |
3 trial(s) available for mirtazapine and lithium
| Article | Year |
|---|---|
Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Confidence Intervals; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipramine; Lithium; Male; Mianserin; Middle Aged; Mirtazapine; Patient Dropouts; Research Design; Survival Analysis; Treatment Outcome | 1998 |
Pharmacokinetics of mirtazapine and lithium in healthy male subjects.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Cognition; Cross-Over Studies; Double-Blind Method; Humans; Lithium; Male; Mianserin; Middle Aged; Mirtazapine; Psychometrics | 2000 |
Keeping our eyes on STAR*D.
Topics: Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium; Mianserin; Mirtazapine; Placebos; Research Design; Tranylcypromine; Treatment Outcome; Triiodothyronine; Venlafaxine Hydrochloride | 2006 |
5 other study(ies) available for mirtazapine and lithium
| Article | Year |
|---|---|
Is the EEG helpful in diagnosing and monitoring lithium intoxication? A case report and review of the literature.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Electroencephalography; Humans; Lithium; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine | 2000 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Subchronic lithium treatment increases the anxiolytic-like effect of mirtazapine on the expression of contextual conditioned fear.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Fear; Lithium; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Sprague-Dawley; Time Factors | 2015 |
Combined treatment with subchronic lithium and acute intracerebral mirtazapine microinjection into the median raphe nucleus exerted an anxiolytic-like effect synergistically.
Topics: Animals; Anti-Anxiety Agents; Conditioning, Psychological; Drug Synergism; Extracellular Space; Fear; Lithium; Male; Mianserin; Microinjections; Mirtazapine; Neurons; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors | 2016 |
Drug Combinations for Mood Disorders and Physical Comorbidities That Need Attention: A Cross-Sectional National Database Survey.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Drug Combinations; Humans; Lithium; Mirtazapine; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors | 2022 |